DE602004025812D1 - N mammakarzinom - Google Patents
N mammakarzinomInfo
- Publication number
- DE602004025812D1 DE602004025812D1 DE602004025812T DE602004025812T DE602004025812D1 DE 602004025812 D1 DE602004025812 D1 DE 602004025812D1 DE 602004025812 T DE602004025812 T DE 602004025812T DE 602004025812 T DE602004025812 T DE 602004025812T DE 602004025812 D1 DE602004025812 D1 DE 602004025812D1
- Authority
- DE
- Germany
- Prior art keywords
- sample
- mamma carcinoma
- tumor
- transmembrane
- emp3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 201000009030 Carcinoma Diseases 0.000 title 1
- 102000027257 transmembrane receptors Human genes 0.000 abstract 2
- 108091008578 transmembrane receptors Proteins 0.000 abstract 2
- 108050007957 Cadherin Proteins 0.000 abstract 1
- 102000000905 Cadherin Human genes 0.000 abstract 1
- 102100030146 Epithelial membrane protein 3 Human genes 0.000 abstract 1
- 101001011788 Homo sapiens Epithelial membrane protein 3 Proteins 0.000 abstract 1
- 101001000631 Homo sapiens Peripheral myelin protein 22 Proteins 0.000 abstract 1
- 101001082860 Homo sapiens Peroxisomal membrane protein 2 Proteins 0.000 abstract 1
- 108050000637 N-cadherin Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010061309 Neoplasm progression Diseases 0.000 abstract 1
- 102100030564 Peroxisomal membrane protein 2 Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000005751 tumor progression Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03015584 | 2003-07-11 | ||
| PCT/EP2004/007561 WO2005005989A1 (en) | 2003-07-11 | 2004-07-09 | A method for predicting the metastatic potential of breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004025812D1 true DE602004025812D1 (de) | 2010-04-15 |
Family
ID=34042827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004025812T Expired - Lifetime DE602004025812D1 (de) | 2003-07-11 | 2004-07-09 | N mammakarzinom |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1646874B1 (de) |
| AT (1) | ATE459886T1 (de) |
| DE (1) | DE602004025812D1 (de) |
| WO (1) | WO2005005989A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006235264A1 (en) * | 2005-04-07 | 2006-10-19 | Novartis Vaccines And Diagnostics Inc. | DDR2 in cancer diagnosis, detection and treatment |
| US8652472B2 (en) | 2006-12-05 | 2014-02-18 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| WO2008086800A2 (en) * | 2007-01-15 | 2008-07-24 | Aarhus Universitet | Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 16 |
| WO2008086799A1 (en) * | 2007-01-15 | 2008-07-24 | Aarhus Universitet | Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 1 (presence) |
| WO2008132752A2 (en) * | 2007-05-01 | 2008-11-06 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Methods and kits for predicting cancer metastasis |
| EP3364190A1 (de) * | 2017-02-20 | 2018-08-22 | Panka Cancer Research AG | Verfahren zum nachweis von krebs oder krebszellen |
| JP2022515140A (ja) * | 2018-12-21 | 2022-02-17 | アイオーニス ファーマシューティカルズ， インコーポレーテッド | Ｐｍｐ２２の発現を低減するための化合物及び方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6680175B2 (en) * | 1998-05-05 | 2004-01-20 | Adherex Technologies, Inc. | Methods for diagnosing and evaluating cancer |
-
2004
- 2004-07-09 WO PCT/EP2004/007561 patent/WO2005005989A1/en active Application Filing
- 2004-07-09 DE DE602004025812T patent/DE602004025812D1/de not_active Expired - Lifetime
- 2004-07-09 AT AT04740845T patent/ATE459886T1/de active
- 2004-07-09 EP EP04740845A patent/EP1646874B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005005989A1 (en) | 2005-01-20 |
| EP1646874A1 (de) | 2006-04-19 |
| EP1646874B1 (de) | 2010-03-03 |
| ATE459886T1 (de) | 2010-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stopfer et al. | High-density, targeted monitoring of tyrosine phosphorylation reveals activated signaling networks in human tumors | |
| DE60043896D1 (de) | Verfahren zum nachweis von lungenneoplasmen in fäkalen proben | |
| NO20074389L (no) | Bestemmelse av respondere til kjemoterapi | |
| EP1492440A4 (de) | Neues verfahren für die diagnose und prognose von malignen erkrankungen | |
| WO2006036788A3 (en) | Methods and compositions for evaluating breast cancer prognosis | |
| ATE508753T1 (de) | Assays und verfahren unter verwendung von biomarkern | |
| WO2004046098A3 (en) | Method for predicting autoimmune diseases | |
| TW200626899A (en) | Frizzled proteins and detection and treatment of cancer | |
| DE60140120D1 (de) | Toxizitätstypisierung unter verwendung von leberstammzellen | |
| BR0313033A (pt) | anticorpos, anticorpos monoclonais, linhagens de células de hibridoma, anticorpos receptores de anti-taci isolados, anticorpos anti -taci, métodos de modulação da atividade biológica | |
| DE60041839D1 (de) | Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs | |
| WO2006123955A3 (en) | Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms | |
| DE602005027848D1 (de) | Tests und verfahren unter verwendung von biomarkern | |
| DE60326748D1 (de) | Verfahren zur identifizierung des brustkrebsrisikos | |
| DE602004025812D1 (de) | N mammakarzinom | |
| Ito et al. | Discovery of futibatinib: The first covalent FGFR kinase inhibitor in clinical use | |
| AU2003253440A1 (en) | Method of diagnosing ovarian endometriosis | |
| DE60038739D1 (de) | Somatostatin analoge, deren radiomarkierte derivate und deren verwendung | |
| Krisp et al. | Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis | |
| DE602004022632D1 (de) | Verwendung von adiponectin zur diagnose von krebs | |
| WO2005002414A3 (en) | Prognosis determination in ewing sarcoma patients by means of genetic profiling | |
| ATE305480T1 (de) | G-protein gekoppelter rezeptor | |
| WO2006063285A3 (en) | Methods for identifying risk of breast cancer or prostate cancer and treatments thereof | |
| EA200600012A1 (ru) | Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку | |
| ATE464553T1 (de) | Verfahren zur herzerkrankungsbewertung in einer einzelperson |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |